Canadian Medical Center (4021) Fundamentals 2026 — P/E 66.7x, Revenue Analysis | SniperIQ
Canadian Medical Center (4021) is a SA-listed Healthcare company in Medical - Care Facilities with a market capitalization of SAR 405M, trading at SAR 5.26 on the SAU. This SniperIQ fundamentals page covers Canadian Medical Center's valuation (P/E 66.7x, P/B 4.3x), profitability (net margin 3.9%), revenue (SAR 148M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Canadian Medical Center's market cap?
Canadian Medical Center (4021) has a market capitalization of approximately SAR 405M, trading at SAR 5.26 on the SAU. Market cap moves with the live share price.
What is Canadian Medical Center's P/E ratio?
Canadian Medical Center's trailing twelve-month P/E ratio is 66.7x, with a price-to-book (P/B) of 4.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Canadian Medical Center?
Canadian Medical Center runs a net profit margin of 3.9%, a gross margin of 27.8%, and an operating margin of 11.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Canadian Medical Center generate?
Canadian Medical Center reported revenue of SAR 148M for fiscal year 2025, with net income of SAR 10M and earnings per share (EPS) of 0.14. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Canadian Medical Center pay a dividend?
Canadian Medical Center offers a trailing dividend yield of about 2.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Canadian Medical Center financially healthy?
Canadian Medical Center carries a debt-to-equity ratio of 0.10x and a current ratio of 3.11x, with a market beta of 0.37. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Canadian Medical Center a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Canadian Medical Center (4021) the key facts are: market cap SAR 405M, P/E 66.7x, revenue SAR 148M, 52-week range 5.18-9.3. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Canadian Medical Center's full fundamentals live
Get Canadian Medical Center's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.